Publication, Part of NICE Technology Appraisals in the NHS in England (Innovation Scorecard)

NICE Technology Appraisals in the NHS in England (Innovation Scorecard) - To September 2019

Official statistics

Publication Date:: 30 Apr 2020
Geographic Coverage:: England
Geographical Granularity:: Regions, Clinical Commissioning Groups, Sustainability and Transformation Partnerships, NHS Trusts
Date Range:: 01 Apr 2015 to 30 Sep 2019

Current Chapter

View all

Next Chapter

Background and Introduction

Summary

The Innovation Scorecard reports on the use of medicines and medical technologies in the NHS in England, which have been positively appraised by the National Institute for Health and Care Excellence (NICE).

NHS Digital has produced and published the Innovation Scorecard as an Official Statistic since January 2013 on behalf of the Office for Life Sciences. It can be used by local NHS organisations to monitor progress in implementing NICE Technology Appraisal (TA) recommendations.

We produce the scorecard using a range of data sources prior to publication and no central data collection is involved.

Note:

Medical Technologies are suspended pending a review of their inclusion criteria and available data sources as a result of developments by the Accelerated Access Collaborative.

The Trust level purchase data dashboard on the online web platform will only show data up to December 2018 as per the previous release.

Latest data to September 2019

What we measure and what we have found

Online Web Platform

Interactive charts, maps and visualisations

Note: It may take up to 1 hour following the 9:30 am release of the official publication for the web platform to become available

Medicines

164 medicines 76% of medicines prescribed more

Medicines are those reported on the Innovation Scorecard only

Medicine Groupings

6 medicine groupings used to treat major conditions All 6 medicine groupings were used more

Medicine groupings are those reported on the Innovation Scorecard only

For the 12 months from October 2018 to September 2019 (compared to the previous 12 months)

Reported as Defined Daily Doses (DDD), Actual Daily Doses (ADD), mgs, vials, tablets, units, implants, pads, interventions or pens/syringes per 100,000 population or QOF register in England

Conditions covered by medicine groupings:

Acute coronary syndrome
Diabetes
Hepatitis C
Multiple sclerosis
Stroke (Separate medicine groupings for stroke by care setting i.e. GP and hospital)

Source: NHS Digital

Key Facts

test

Administrative Sources

• English Prescribing Dataset (EPD) published by the NHS Business Services Authority • Secondary Care Medicines Data (SCMD) published by the NHS Business Services Authority • Hospital Episode Statistics (HES) data from NHS England • Population data from Office for National Statistics